Clinical predictors of escalating care in hepatic and renal cyst infection in autosomal dominant polycystic kidney and liver disease

Autor: M A, Lantinga, R G L, de Sévaux, T J G, Gevers, W J G, Oyen, J W, de Fijter, D, Soonawala, R, Zietse, M, Salih, N F, Casteleijn, E M, Spithoven, E, Meijer, R T, Gansevoort, J P H, Drenth On Behalf Of The Dipak Consortium

Publikováno v: The Netherlands Journal of Medicine. 76(5):226-234

BACKGROUND: Cyst infection may occur in autosomal dominant polycystic kidney disease (ADPKD) and autosomal dominant polycystic liver disease (ADPLD). Antimicrobial agents often fail to control infection, leading to invasive action. We aimed to identi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::95b3bedaf4f2a97b9b059c9e81b72ec5
https://hdl.handle.net/11370/bc360867-bdb4-4b82-9f52-c49ea5d76ff4

The continuous debate in literature about the usage of iodine-131 dosing for the ablation of thyroid remnants and metastases

Autor: J M H, De Klerk, W J G, Oyen

Publikováno v: Minerva endocrinologica. 34(1)

Radioiodine plays an important role in the treatment of thyroid cancer. It is used for thyroid remnant ablation as well as for treatment of metastatic disease. Despite the fact that it is used all over the world for these indications, the exact admin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::33ff4e42db58408a37658dd8211f4eb1
https://pubmed.ncbi.nlm.nih.gov/19209128

The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours

Autor: J R, Spermon, L F, De Geus-Oei, L A L M, Kiemeney, J A, Witjes, W J G, Oyen

Publikováno v: BJU international. 89(6)

To investigate the role of 18fluoro-2-deoxyglucose positron emission tomography (FDG-PET) in the initial staging of clinical stage I and II nonseminomatous germ cell tumours (NSGCTs) and in re-staging (non)seminomatous GCTs after chemotherapy.FDG-PET

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1e99c6b3eca5029a8ede1c4999f232f1
https://pubmed.ncbi.nlm.nih.gov/11942962

Targeted therapy in nuclear medicine current status and future prospects.

Autor: W. J. G. Oyen, L. Bodei, F. Giammarile, H. R. Maecke, J. Tennvall, M. Luster, B. Brans

Publikováno v: Annals of Oncology. Nov2007, Vol. 18 Issue 11, p1782-1782. 1p.

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort ^† : Under the Auspices of the EAU-ESMO Guidelines Committees.

Autor: Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Fred.Witjes@radboudumc.nl., Babjuk M; Depatment of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic; Department of Urology, Medical University of Vienna, Vienna, Austria., Bellmunt J; IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain; Harvard Medical School, Boston, Massachusetts, USA., Bruins HM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., De Reijke TM; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands., De Santis M; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Charité University Hospital, Berlin, Germany., Gillessen S; Division of Cancer Sciences, University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK; Division of Oncology and Haematology, Kantonsspital St Gallen, St Gallen, Switzerland; University of Bern, Bern, Switzerland., James N; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Maclennan S; Academic Urology Unit, University of Aberdeen, Aberdeen, UK., Palou J; Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Powles T; The Royal Free NHS Trust, London, UK; Barts Cancer Institute, Queen Mary University of London, London, UK., Ribal MJ; Uro-Oncology Unit, Hospital Clinic, University of Barcelona, Spain., Shariat SF; Depatment of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, New York, USA; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia., Der Kwast TV; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands., Xylinas E; Department of Urology, Bichat-Claude Bernard Hospital, Assistance Publique Hôpitaux de Paris, Paris, France; Paris Descartes University, Paris, France., Agarwal N; Huntsman Cancer Institute, University of Utah (NCI-CCC), Salt Lake City, Utah, USA., Arends T; Urology Department, Canisius-Wilhelmina Ziekenhuis Nijmegen, The Netherlands., Bamias A; 2nd Propaedeutic Dept of Internal Medicine, Medical School, National & Kapodistrian University of Athens, Athens, Greece., Birtle A; Division of Cancer Sciences, University of Manchester, Manchester, UK; Rosemere Cancer Centre, Lancashire Teaching Hospitals, Preston, UK., Black PC; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Colombia, Canada., Bochner BH; Department of Urology, Weill Cornell Medical College, New York, New York, USA; Urology Service, Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Bolla M; Emeritus Professor of Radiation Oncology, Grenoble - Alpes University, Grenoble, France., Boormans JL; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands., Bossi A; Department of Radiation Oncology, Gustave Roussy Institute, Villejuif, France., Briganti A; Department of Urology, Urological Research Institute, Milan; Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy., Brummelhuis I; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Burger M; Department of Urology, Caritas-St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Castellano D; Medical Oncology Department, 12 de Octubre University Hospital (CIBERONC), Madrid, Spain., Cathomas R; Departement Innere Medizin, Abteilung Onkologie und Hämatologie, Kantonsspital Graubünden, Chur, Switzerland., Chiti A; Department of Biomedical Sciences, Humanitas University, Milan, Italy; Humanitas Research Hospital, Milan, Italy., Choudhury A; Division of Cancer Sciences, University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK., Compérat E; Department of Pathology, Tenon hospital, HUEP, Paris, France; Sorbonne University, Paris, France., Crabb S; Cancer Sciences Unit, University of Southampton, Southampton, UK., Culine S; Department of Cancer Medicine, Hôpital Saint Louis, Paris, France., De Bari B; Radiation Oncology Department, Centre Hospitalier Régional Universitaire 'Jean Minjoz' of Besançon, INSERM UMR 1098, Besançon, France; Radiation Oncology Department, Centre Hospitalier Universitaire Vaudois, Université de Lausanne, Lausanne, Switzerland., De Blok W; Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands., J L De Visschere P; Department of Radiology and Nuclear Medicine, Division of Genitourinary Radiology and Mammography, Ghent University Hospital, Ghent, Belgium., Decaestecker K; Department of Urology, Ghent University Hospital, Ghent, Belgium., Dimitropoulos K; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK., Dominguez-Escrig JL; Servicio de Urología, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Fanti S; Department of Nuclear Medicine, Policlinico S Orsola, University of Bologna, Italy., Fonteyne V; Department of Radiotherapy Oncology, Ghent University Hospital, Ghent, Belgium., Frydenberg M; Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia., Futterer JJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Gakis G; Department of Urology and Paediatric Urology, University Hospital of Würzburg, Julius-Maximillians University, Würzburg, Germany., Geavlete B; Department of Urology, Saint John Emergency Clinical Hospital, Bucharest, Romania., Gontero P; Division of Urology, Molinette Hospital, University of Studies of Torino, Torino, Italy., Grubmüller B; Department of Urology, Medical University of Vienna, Vienna, Austria., Hafeez S; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Department of Clinical Oncology, The Royal Marsden NHS Foundation Trust, London, UK., Hansel DE; Department of Urology, University of California, San Diego Pathology, La Jolla, California, USA., Hartmann A; Institute of Pathology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Erlangen, Germany., Hayne D; Department of Urology, UWA Medical School, University of Western Australia, Perth, Australia., Henry AM; Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Hernandez V; Department of Urology, Hospital Universitario Fundación de Alcorcón, Madrid, Spain., Herr H; Urology Service, Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Herrmann K; Department of Nuclear Medicine, Universitätsklinikum Essen, Essen, Germany., Hoskin P; Division of Cancer Sciences, University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK; Mount Vernon Centre for Cancer Treatment, London, UK., Huguet J; Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Jereczek-Fossa BA; Department of Oncology and Hemato-oncology, University of Milan, Milan; Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milan, Italy., Jones R; Institute of Cancer Sciences, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Kamat AM; Department of Urology - Division of Surgery, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Khoo V; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Department of Clinical Oncology, The Royal Marsden NHS Foundation Trust, London, UK; Department of Medicine, University of Melbourne; Monash University, Melbourne, Australia., Kiltie AE; CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK., Krege S; Department of Urology, Pediatric Urology and Urologic Oncology, Kliniken Essen-Mitte, Essen, Germany., Ladoire S; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France., Lara PC; Department of Oncology, Hospital Universitario San Roque; Universidad Fernando Pessoa, Canarias, Spain., Leliveld A; Department of Urology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Linares-Espinós E; Department of Urology, University Hospital La Paz, Madrid, Spain., Løgager V; Department of Radiology, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark., Lorch A; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Loriot Y; Département de Médecine Oncologique, Gustave Roussy, INSERM U981, Université Paris-Sud, Université Paris-Saclay, Villejuif, France., Meijer R; UMC Utrecht Cancer Center, MS Oncologic Urology, Utrecht, The Netherlands., Mir MC; Servicio de Urología, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Moschini M; Department of Urology, Luzerner Kantonsspital, Luzern, Switzerland., Mostafid H; Department of Urology, Royal Surrey County Hospital, Guildford, UK., Müller AC; Department of Radiation Oncology, Eberhard Karls University, Tübingen, Germany., Müller CR; Cancer Treatment Centre, Sorlandet Hospital, Kristiansand, Norway., N'Dow J; Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK., Necchi A; Department of Medical Oncology, Istituto Nazionale Tumori of Milan, Milan, Italy., Neuzillet Y; Department of Urology, Hospital Foch, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France., Oddens JR; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands., Oldenburg J; Department of Oncology, Akershus University Hospital, Lørenskog, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway., Osanto S; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands., J G Oyen W; Department of Biomedical Sciences, Humanitas University, Milan, Italy; Humanitas Research Hospital, Milan, Italy; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands., Pacheco-Figueiredo L; Department of Urology, Centro Hospitalar São João, Porto, Portugal; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal., Pappot H; Department of Oncology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark., Patel MI; Department of Urology, Westmead Hospital, University of Sydney, Sydney, Australia., Pieters BR; Department Radiation Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Plass K; EAU Guidelines Office, Arnhem, The Netherlands., Remzi M; Department of Urology, Medical University of Vienna, Vienna, Austria., Retz M; Department of Urology, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany., Richenberg J; Department of Imaging and Nuclear Medicine, Royal Sussex County Hospital, Brighton, UK; Brighton and Sussex Medical School, Brighton, UK., Rink M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Roghmann F; Department of Urology, Ruhr-University Bochum, Marien Hospital, Herne, Germany., Rosenberg JE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Weill Cornell Medical College, New York, New York, USA., Rouprêt M; Department of Urology, Sorbonne Université, GRC n°5, ONCOTYPE-URO, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France., Rouvière O; Hospices Civils de Lyon, Service d'Imagerie Urinaire et Vasculaire, Hôpital Edouard Herriot, Lyon, France; Université de Lyon, Université Lyon 1, faculté de médecine Lyon Est, Lyon, France., Salembier C; Department of Radiation Oncology, Europe Hospitals Brussels, Belgium., Salminen A; Department of Urology, University Hospital of Turku, Finland., Sargos P; Department of Radiotherapy, Institut Bergonié, Bordeaux, France., Sengupta S; Department of Surgery, Austin Health, University of Melbourne, Melbourne, Australia; Eastern Health Clinical School, Monash University, Melbourne, Australia., Sherif A; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå university, Umeå, Sweden., Smeenk RJ; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Smits A; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Stenzl A; Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany., Thalmann GN; Department of Urology, Inselspital, Bern University Hospital, Bern, Switzerland., Tombal B; Division of Urology, IREC, Cliniques Universitaires Saint Luc, UCL, Brussels, Belgium., Turkbey B; Molecular Imaging Program, National Cancer Institute, Bethesda, Maryland, USA., Lauridsen SV; Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Valdagni R; Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Van Der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Van Poppel H; Department of Urology, University Hospitals Leuven, Belgium., Vartolomei MD; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Cell and Molecular Biology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania., Veskimäe E; Department of Urology, Tampere University Hospital, Tampere, Finland., Vilaseca A; Uro-Oncology Unit, Hospital Clinic, University of Barcelona, Spain., Rivera FAV; Clinica HematoOncologica Bonadona Prevenir, Universidad Metropolitana, Clinica Club de Leones, Barranquilla, Colombia., Wiegel T; Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany., Wiklund P; Icahn School of Medicine, Mount Sinai Health System New York City, New York, USA; Department of Urology, Karolinska Institutet, Stockholm, Sweden., Williams A; Department of Urology, Auckland City Hospital, Auckland, New Zealand., Zigeuner R; Department of Urology, Medizinische Universität Graz, Graz, Austria., Horwich A; Emeritus Professor, The Institute of Cancer Research, London, UK.

Publikováno v: European urology [Eur Urol] 2020 Feb; Vol. 77 (2), pp. 223-250. Date of Electronic Publication: 2019 Nov 19.